Literature DB >> 6530537

DOCA-salt induced malignant hypertension in spontaneously hypertensive rats.

S Sesoko, B L Pegram, G W Willis, E D Frohlich.   

Abstract

DOCA-salt hypertension was produced in 10 male 10-week-old normotensive Wistar-Kyoto (WKY) rats receiving deoxycorticosterone acetate (DOCA; 100 mg/kg, subcutaneous pellet) and 1% NaCl drinking water and was compared with data from 10 age- and sex-matched WKY receiving normal tap water (C). These data were also compared with spontaneously hypertensive (SHR) rats similarly treated. After 10 weeks on these programmes, systemic and regional haemodynamics were determined in conscious rats using microsphere techniques. DOCA-salt treatment increased mean arterial pressure (MAP), total peripheral resistance index (TPRI), cardiac and renal weights in both WKY and SHR. In contrast to SHR (C), the SHR (DOCA) demonstrated more severe MAP elevation (204 +/- 4 versus 185 +/- mmHg; P less than 0.01), more severe systemic and regional (especially renal) vasoconstriction, and malignant vasculitis associated with azotaemia and hyperuricaemia. The hyperuricaemia was related inversely to renal blood flow (r = -0.74; P less than 0.01) and directly to renal vasoconstriction (r = 0.65; P less than 0.05) in SHR (DOCA). These data suggest that in both WKY and SHR, DOCA and salt produced marked cardiovascular changes and SHR rats developed malignant hypertension.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6530537     DOI: 10.1097/00004872-198402000-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Genetic susceptibility to hypertension-induced renal damage in the rat. Evidence based on kidney-specific genome transfer.

Authors:  P C Churchill; M C Churchill; A K Bidani; K A Griffin; M Picken; M Pravenec; V Kren; E St Lezin; J M Wang; N Wang; T W Kurtz
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 2.  Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system.

Authors:  Xiaoyan Zhou; Luis Matavelli; Edward D Frohlich
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

Review 3.  Hyperuricemia: A Biomarker of Renal Hemodynamic Impairment.

Authors:  Dinko Susic; Edward D Frohlich
Journal:  Cardiorenal Med       Date:  2015-06       Impact factor: 2.041

4.  Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.

Authors:  E L Schiffrin; P Sventek; J S Li; A Turgeon; T Reudelhuber
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.